US, EU pledge $2B+ to help boost vac­cine man­u­fac­tur­ing in Africa

11 months ago
Manufacturing

Mon­cef Slaoui joins board at mR­NA biotech; Gami­da Cell re­tools with ex-Am­ryt CEO at the helm

11 months ago
Peer Review

FDA widens Sarep­ta’s Duchenne gene ther­a­py la­bel to old­er boys in sig­nif­i­cant ex­pan­sion of use

11 months ago
Pharma
Cell/Gene Tx

Tec­ton­ic en­ters pub­lic mar­kets in one of few biotech re­verse merg­ers this year

11 months ago
Startups
Deals

Gilead­'s twice-a-year in­jec­tion ful­ly pre­vent­ed HIV in Phase 3 study with cis­gen­der women

11 months ago
R&D

Sci­en­tists just dis­cov­ered a new ge­net­ic clue for de­lay­ing Alzheimer’s dis­ease. It’s al­ready in­spir­ing drug ...

11 months ago
R&D

Zealand Phar­ma hits ear­ly ef­fi­ca­cy goal for amylin weight loss can­di­date

11 months ago
R&D
Pharma

FDA to phar­ma com­pa­nies: Us­ing CRO Synapse's stud­ies 'u­nac­cept­able'

11 months ago
Outsourcing
Pharma

CBER chief floats rare dis­ease hub to bet­ter com­mu­ni­cate across cen­ters

11 months ago
Pharma
FDA+

Take­da bud­gets $230M for plas­ma ther­a­py fa­cil­i­ty ex­pan­sion in Cal­i­for­nia

11 months ago
Manufacturing

An­oth­er fire breaks out at a No­vo Nordisk site; Ther­mo Fish­er ear­marks $58M in­to a new lab

11 months ago
Manufacturing

Cor­rect­ed: Emer­gent sells Bal­ti­more fa­cil­i­ty for $30M

11 months ago
Pharma
Manufacturing

Jaz­z's stock dips af­ter mid-stage fail in es­sen­tial tremor

11 months ago
R&D

PTC touts Phase 2 bio­mark­er da­ta for Hunt­ing­ton’s drug, show­ing dose-de­pen­dent ef­fect at one year

11 months ago
R&D

FDA makes it eas­i­er for biosim­i­lars to ob­tain in­ter­change­abil­i­ty des­ig­na­tions

11 months ago
FDA+

Si­lence’s siR­NA can­di­date for car­dio­vas­cu­lar dis­ease con­tin­ues to de­liv­er in Phase 2 tri­al

11 months ago
R&D

For­bion's new €75M fund; Cara Ther­a­peu­tics to cut work­force af­ter tri­al fail­ure

11 months ago
News Briefing

Apha­ia hits pri­ma­ry end­point with oral glu­cose drug in mid-stage pre­di­a­betes tri­al

11 months ago
R&D

Gilead test­ed an an­ti­body many times. A small biotech sal­vages it, with $40M and ‘con­vic­tion’ else­where

11 months ago
Financing
Startups

Lil­ly cracks down fur­ther on com­pound­ed tirzepatide as GLP-1 short­age starts to ease

11 months ago
People
Law

iOnc­tura rais­es €80M to ad­vance ear­ly-stage rare eye can­cer treat­ment

11 months ago
Financing
R&D

Sam­sung Bio and Bax­ter di­al up man­u­fac­tur­ing deal to $223M

11 months ago
Deals
Manufacturing

Blank check, please? Three health­care SPACs re­veal their IPO plans

11 months ago
Financing

Ab­b­Vie adds ul­cer­a­tive col­i­tis to Skyrizi la­bel

11 months ago
Pharma
FDA+
First page Previous page 140141142143144145146 Next page Last page
A service from the Financial Times